Loblaw Companies Limited · TSX:L
Loblaw Companies — Q2 2025 Earnings Presentation
5 slides from Loblaw Companies's earnings presentation, Jun 14, 2025
Slide 1: Supplementary Slides Q2 2025
SUPPLEMENTARY SLIDES Q2 2025 For the periods ended June 14, 2025 and June 15, 2024 1
Slide 2: Forward Looking Statements
FORWARD LOOKING STATEMENTS This presentation for Loblaw Companies Limited (“Loblaw” or “the Company”) contains forward-looking statements about the Company’s objectives, plans, goals, aspirations, strategies, financial condition, results of operations, cash flows, performance, prospects, opportuniti
Slide 3: Key Financial Metrics – Consolidated
KEY FINANCIAL METRICS – Consolidated Q2 2025 (millions of Canadian dollars unless otherwise noted) Q2 2025 Q2 2024 % Change (1) Consolidated Revenue $14,672 $13,947 ↑ +5.2% Adjusted EBITDA $1,840 $1,713 ↑ +7.4% Adjusted EBITDA Margin 12.5% 12.3% ↑ 20bps Adjusted Net Earnings Avaliable to Common Shar
Slide 4: Key Financial Metrics – Retail Segment
KEY FINANCIAL METRICS – Retail Segment Q2 2025 (millions of Canadian dollars unless otherwise noted) Q2 2025 Q2 2024 % Change (1) Total Retail Revenue $14,389 $13,658 ↑ 5.4% Retail Revenue - Food $10,213 $9,653 ↑ 5.8% Retail Revenue - Drug $4,176 $4,005 ↑ 4.3% Pharmacy and Healthcare Services $2,255
Slide 5: Key Operational Metrics
KEY OPERATIONAL METRICS Q2 2025 Food Retail (Loblaw) % Change (1) Food Retail Same-Store Sales Growth ↑ +3.5% Basket Size(2) ↑ Traffic(2) ↑ Loblaw STM Square Footage Growth ↑ Industry STM Square Footage Growth ↑ Drug Retail (Shoppers Drug Mart) % Change (1) Drug Retail Same-Store Sales Growth ↑ +4.1